JP2020127419A5 - - Google Patents

Download PDF

Info

Publication number
JP2020127419A5
JP2020127419A5 JP2020081545A JP2020081545A JP2020127419A5 JP 2020127419 A5 JP2020127419 A5 JP 2020127419A5 JP 2020081545 A JP2020081545 A JP 2020081545A JP 2020081545 A JP2020081545 A JP 2020081545A JP 2020127419 A5 JP2020127419 A5 JP 2020127419A5
Authority
JP
Japan
Prior art keywords
analog
seq
shk
analog according
toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020081545A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020127419A (ja
JP6953579B2 (ja
Filing date
Publication date
Priority claimed from JP2017508102A external-priority patent/JP6847828B2/ja
Application filed filed Critical
Publication of JP2020127419A publication Critical patent/JP2020127419A/ja
Publication of JP2020127419A5 publication Critical patent/JP2020127419A5/ja
Application granted granted Critical
Publication of JP6953579B2 publication Critical patent/JP6953579B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020081545A 2014-08-15 2020-05-01 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用 Active JP6953579B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014903189A AU2014903189A0 (en) 2014-08-15 Novel potassium channel blockers
AU2014903189 2014-08-15
JP2017508102A JP6847828B2 (ja) 2014-08-15 2015-08-14 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017508102A Division JP6847828B2 (ja) 2014-08-15 2015-08-14 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用

Publications (3)

Publication Number Publication Date
JP2020127419A JP2020127419A (ja) 2020-08-27
JP2020127419A5 true JP2020127419A5 (https=) 2020-11-12
JP6953579B2 JP6953579B2 (ja) 2021-10-27

Family

ID=55303691

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017508102A Active JP6847828B2 (ja) 2014-08-15 2015-08-14 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用
JP2020081545A Active JP6953579B2 (ja) 2014-08-15 2020-05-01 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017508102A Active JP6847828B2 (ja) 2014-08-15 2015-08-14 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用

Country Status (5)

Country Link
US (1) US10246496B2 (https=)
EP (1) EP3180365B1 (https=)
JP (2) JP6847828B2 (https=)
AU (1) AU2015303825B2 (https=)
WO (1) WO2016023072A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6847828B2 (ja) * 2014-08-15 2021-03-24 モナッシュ ユニバーシティ 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用
KR102533290B1 (ko) * 2022-04-14 2023-05-16 한국해양과학기술원 전압개폐 칼륨이온채널 억제 활성능을 갖는 펩타이드
KR102553070B1 (ko) * 2022-06-16 2023-07-07 한국해양과학기술원 전압개폐 칼륨이온채널 억제 활성능을 갖는 작은상자해파리 기원 펩타이드

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2474316B1 (en) * 2004-10-07 2016-04-06 The Regents of The University of California Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels
PE20081140A1 (es) * 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
CN101796069B (zh) * 2007-05-14 2014-02-19 墨西哥国立自治大学 Vm23和Vm24,两种以高选择性阻断人类T淋巴细胞钾通道(Kv1.3亚型)并降低大鼠的体内DTH反应的蝎子肽
EP2408814B1 (en) * 2009-03-20 2018-11-21 Amgen Inc. Carrier immunoglobulins and uses thereof
WO2012170392A2 (en) * 2011-06-06 2012-12-13 Kineta One, Llc Shk-based pharmaceutical compositions and methods of manufacturing and using the same
RS57422B1 (sr) * 2013-01-25 2018-09-28 Janssen Biotech Inc Antagonisti kv1.3 i postupci za upotrebu
JP6847828B2 (ja) * 2014-08-15 2021-03-24 モナッシュ ユニバーシティ 新規なカリウムチャネルブロッカー及び自己免疫疾患の治療におけるそれらの使用

Similar Documents

Publication Publication Date Title
JP2020127419A5 (https=)
JP2018138049A5 (https=)
JP2019527555A5 (https=)
SA522433360B1 (ar) L-أَسْباراجيناز مُعدل
JP2017018125A5 (https=)
JP2004267216A5 (https=)
JP2006516189A5 (https=)
JP2009527226A5 (https=)
Buckland et al. Fusion glycoprotein of measles virus: nucleotide sequence of the gene and comparison with other paramyxoviruses
JP2013027391A5 (https=)
NZ603348A (en) Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
JP2024041747A5 (https=)
JP2020517260A5 (https=)
JP2019534884A5 (https=)
JP2017221201A5 (https=)
EP2589658A4 (en) PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN
JP2018537089A5 (https=)
JP2014193147A5 (https=)
JP2011521661A5 (https=)
JP2008545393A5 (https=)
JP2017513849A5 (https=)
JP2002517193A5 (https=)
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
JP2004535161A5 (https=)
DE60336353D1 (de) Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung